tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:CHM Stock Latest News

Chimeric Therapeutics Achieves Promising Results in CHM CDH17 Clinical Trial
Company AnnouncementsChimeric Therapeutics Achieves Promising Results in CHM CDH17 Clinical Trial
1d ago
CHM
Chimeric Therapeutics Issues Disclaimer on Forward-Looking Statements
PremiumCompany Announcements
Chimeric Therapeutics Issues Disclaimer on Forward-Looking Statements
21d ago
CHM
Chimeric Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Chimeric Therapeutics Releases 2025 Corporate Governance Statement
1M ago
CHM
Chimeric Therapeutics Reports Revenue Growth and Reduced Losses
PremiumCompany Announcements
Chimeric Therapeutics Reports Revenue Growth and Reduced Losses
1M ago
CHM
Chimeric Therapeutics to Host Webinar on Innovative CAR T Therapy
PremiumCompany Announcements
Chimeric Therapeutics to Host Webinar on Innovative CAR T Therapy
1M ago
CHM
Chimeric Therapeutics Director Acquires Significant Shareholding
PremiumCompany AnnouncementsChimeric Therapeutics Director Acquires Significant Shareholding
1M ago
CHM
Chimeric Therapeutics Issues Unquoted Securities
Premium
Company Announcements
Chimeric Therapeutics Issues Unquoted Securities
2M ago
CHM
Chimeric Therapeutics Expands Market Presence with New ASX Securities Quotation
Premium
Company Announcements
Chimeric Therapeutics Expands Market Presence with New ASX Securities Quotation
2M ago
CHM
Chimeric Therapeutics Advances CHM CDH17 Clinical Trial with Promising Results
PremiumCompany Announcements
Chimeric Therapeutics Advances CHM CDH17 Clinical Trial with Promising Results
2M ago
CHM
Chimeric Therapeutics Announces Change in Substantial Holder Interests
PremiumCompany Announcements
Chimeric Therapeutics Announces Change in Substantial Holder Interests
2M ago
CHM
Chimeric Therapeutics Advances Cancer Treatment with Key Milestones and Funding
PremiumCompany Announcements
Chimeric Therapeutics Advances Cancer Treatment with Key Milestones and Funding
2M ago
CHM
Chimeric Therapeutics to Issue 11 Million New Securities
PremiumCompany Announcements
Chimeric Therapeutics to Issue 11 Million New Securities
2M ago
CHM
Chimeric Therapeutics Issues New Unquoted Equity Securities
PremiumCompany AnnouncementsChimeric Therapeutics Issues New Unquoted Equity Securities
2M ago
CHM
Chimeric Therapeutics Announces Quotation of New Securities on ASX
Premium
Company Announcements
Chimeric Therapeutics Announces Quotation of New Securities on ASX
2M ago
CHM
Chimeric Therapeutics Issues Over 1.25 Billion Unquoted Equity Securities
Premium
Company Announcements
Chimeric Therapeutics Issues Over 1.25 Billion Unquoted Equity Securities
2M ago
CHM
Chimeric Therapeutics Lists Over 1 Billion New Securities on ASX
PremiumCompany Announcements
Chimeric Therapeutics Lists Over 1 Billion New Securities on ASX
2M ago
CHM
Chimeric Therapeutics Issues New Shares and Options Following Shareholder Approval
PremiumCompany Announcements
Chimeric Therapeutics Issues New Shares and Options Following Shareholder Approval
2M ago
CHM
Chimeric Therapeutics Announces Proposed Securities Issue
PremiumCompany Announcements
Chimeric Therapeutics Announces Proposed Securities Issue
2M ago
CHM
Chimeric Therapeutics Concludes Lind Agreement with New Securities Issuance
PremiumCompany Announcements
Chimeric Therapeutics Concludes Lind Agreement with New Securities Issuance
2M ago
CHM
Chimeric Therapeutics Secures Shareholder Approval at Extraordinary Meeting
PremiumCompany AnnouncementsChimeric Therapeutics Secures Shareholder Approval at Extraordinary Meeting
2M ago
CHM
Chimeric Therapeutics Issues Disclaimer on Forward-Looking Statements
Premium
Company Announcements
Chimeric Therapeutics Issues Disclaimer on Forward-Looking Statements
2M ago
CHM
Chimeric Therapeutics Appoints New Director, Miles Prince
Premium
Company Announcements
Chimeric Therapeutics Appoints New Director, Miles Prince
3M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >